Qian Yu, MD

CIO 2023-34 Radioembolization Plus Gemcitabine, Cisplatin, and Capecitabine as First-Line Therapy for Intrahepatic Cholangiocarcinoma

Purpose: To report outcomes of an institutional downstaging protocol for intrahepatic cholangiocarcinoma (iCCA) using radioembolization (TARE), gemcitabine, cisplatin, and capecitabine co...

Yating Wang , MD;

Mikin Patel , MD;

Thuong Van Ha , MD;

John Fung , MD;

Anjana Pillai , MD;

Osman Ahmed , MD;

Chih-Yi Liao , MD;

Talia Baker , MD;

Qian Yu , MD;

11/02/2023

CIO 2023-33 Tumor Size and Watershed Area Correlates in Progression of Hepatocellular Carcinoma after Segmental Radioembolization

Purpose: To identify factors of incomplete treatment after segmental transarterial radioembolization (TARE) for treatment-naïve and solitary hepatocellular carcinoma (HCC)

Osman Ahmed , MD;

Qian Yu , MD;

Mikin Patel , MD;

Thuong Van Ha , MD;

Anjana Pillai , MD;

Monika Neale , DO, PGY-1;

Ethan Ungchusri , MD;

Natalie Rothenberger , MD;

Rakesh Navuluri , MD;

11/02/2023